Venetoclax vs. BTKis in CLL Treatment

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

City of Hope

www.cityofhope.org

Breast
Lung
Gastrointestinal
Genitourinary
Gynecologic Oncology
Leukemia
Lymphoma
Myeloma
Hematologic Malignancies
Head and Neck
General Oncology
Palliative Care
Events

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time -0:00

0.5x
0.75x
1x, selected
1.25x
1.5x
1.75x
2x

Chapters

descriptions off, selected

captions settings, opens captions settings dialog
captions off, selected

This is a modal window.

Beginning of dialog window. Escape will cancel and close the window.

TextColorTransparency

BackgroundColorTransparency

WindowColorTransparency

Font Size

Text Edge Style

Font Family

End of dialog window.

10 seconds

Playback speed

This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.

Venetoclax vs. BTKis in CLL Treatment

By City of Hope FEATURING Alexey Danilov

266 views

June 28, 2024

Comments 0

Insights on Proteasome Inhibitor Combinations at First Relapse in Mu…

Feat. M. Levy

Leukemia

New

Tandem 2025 Insights: Outcomes of Adult AML Patients Who Received Ve…

Insights from 2025 Tandem Annual Meeting

A. Artz

Acute GVHD: Demographics, Diagnosis, Pathophysiology, and Advancemen…

City of Hope

A. Salhotra

105 views

ASH 2024 Summary: CLL Highlights

2024 ASH Annual Meeting Insights Hub

A. Danilov

276 views

ASH 2024 Insights: Epcoritamab Monotherapy in R/R CLL - Expansion an…

2024 ASH Annual Meeting Insights Hub

A. Danilov

32 views

Incorporating Pirtobrutinib and CAR-T Therapy Into CLL Practice

City of Hope

A. Danilov

47 views

CLL Treatment Sequencing: The Importance of First Choice

City of Hope

S. Rosen

322 views